Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors

Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors

In this cohort study of 23,680 AET-eligible patients, AIAN women had the lowest AET-adherence by the end of the 5-year period and total underutilization (combining initiation and adherence) was greatest among AIAN (70.6%), followed by Black (69.6%), Hispanic (63.2%), non-Hispanic white (58.7%), and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2021-02, Vol.127 (11), p.1847-1856
Hauptverfasser: Emerson, Marc A., Achacoso, Ninah S., Benefield, Halei C., Troester, Melissa A., Habel, Laurel A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1856
container_issue 11
container_start_page 1847
container_title Cancer
container_volume 127
creator Emerson, Marc A.
Achacoso, Ninah S.
Benefield, Halei C.
Troester, Melissa A.
Habel, Laurel A.
description In this cohort study of 23,680 AET-eligible patients, AIAN women had the lowest AET-adherence by the end of the 5-year period and total underutilization (combining initiation and adherence) was greatest among AIAN (70.6%), followed by Black (69.6%), Hispanic (63.2%), non-Hispanic white (58.7%), and Asian/Pacific Islander (52.3%), underscoring the AET-treatment gap.
doi_str_mv 10.1002/cncr.33423
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8191495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8191495</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_81914953</originalsourceid><addsrcrecordid>eNqljLtOwzAUhi0EouWy8ATnAUhrxwlpFqQKgejCxMAWnTiH1iU5jmwnUleeHA8szEy_vv8mxJ2SKyVlvjZs_ErrItdnYqlkXWVSFfm5WEopN1lZ6I-FuArhmLDKS30pFlo_5LIq9VJ879hGi9E6BuQOsDuQJzYE0SU4TjNyBOLOGW85uSnG8QQ4ON7D5Fvke7AcJk8dbAfy1iDDjjuLvN72GL4SvqX_maD1hCFCKhjykCaznZ0PN-LiE_tAt796LR5fnt-fXrNxagfqDHH02DejtwP6U-PQNn8Ttodm7-Zmo2pV1KX-98EPeN5wzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors</title><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><source>Alma/SFX Local Collection</source><creator>Emerson, Marc A. ; Achacoso, Ninah S. ; Benefield, Halei C. ; Troester, Melissa A. ; Habel, Laurel A.</creator><creatorcontrib>Emerson, Marc A. ; Achacoso, Ninah S. ; Benefield, Halei C. ; Troester, Melissa A. ; Habel, Laurel A.</creatorcontrib><description>In this cohort study of 23,680 AET-eligible patients, AIAN women had the lowest AET-adherence by the end of the 5-year period and total underutilization (combining initiation and adherence) was greatest among AIAN (70.6%), followed by Black (69.6%), Hispanic (63.2%), non-Hispanic white (58.7%), and Asian/Pacific Islander (52.3%), underscoring the AET-treatment gap.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.33423</identifier><identifier>PMID: 33620753</identifier><language>eng</language><ispartof>Cancer, 2021-02, Vol.127 (11), p.1847-1856</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27926,27927</link.rule.ids></links><search><creatorcontrib>Emerson, Marc A.</creatorcontrib><creatorcontrib>Achacoso, Ninah S.</creatorcontrib><creatorcontrib>Benefield, Halei C.</creatorcontrib><creatorcontrib>Troester, Melissa A.</creatorcontrib><creatorcontrib>Habel, Laurel A.</creatorcontrib><title>Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors</title><title>Cancer</title><description>In this cohort study of 23,680 AET-eligible patients, AIAN women had the lowest AET-adherence by the end of the 5-year period and total underutilization (combining initiation and adherence) was greatest among AIAN (70.6%), followed by Black (69.6%), Hispanic (63.2%), non-Hispanic white (58.7%), and Asian/Pacific Islander (52.3%), underscoring the AET-treatment gap.</description><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqljLtOwzAUhi0EouWy8ATnAUhrxwlpFqQKgejCxMAWnTiH1iU5jmwnUleeHA8szEy_vv8mxJ2SKyVlvjZs_ErrItdnYqlkXWVSFfm5WEopN1lZ6I-FuArhmLDKS30pFlo_5LIq9VJ879hGi9E6BuQOsDuQJzYE0SU4TjNyBOLOGW85uSnG8QQ4ON7D5Fvke7AcJk8dbAfy1iDDjjuLvN72GL4SvqX_maD1hCFCKhjykCaznZ0PN-LiE_tAt796LR5fnt-fXrNxagfqDHH02DejtwP6U-PQNn8Ttodm7-Zmo2pV1KX-98EPeN5wzg</recordid><startdate>20210223</startdate><enddate>20210223</enddate><creator>Emerson, Marc A.</creator><creator>Achacoso, Ninah S.</creator><creator>Benefield, Halei C.</creator><creator>Troester, Melissa A.</creator><creator>Habel, Laurel A.</creator><scope>5PM</scope></search><sort><creationdate>20210223</creationdate><title>Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors</title><author>Emerson, Marc A. ; Achacoso, Ninah S. ; Benefield, Halei C. ; Troester, Melissa A. ; Habel, Laurel A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_81914953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Emerson, Marc A.</creatorcontrib><creatorcontrib>Achacoso, Ninah S.</creatorcontrib><creatorcontrib>Benefield, Halei C.</creatorcontrib><creatorcontrib>Troester, Melissa A.</creatorcontrib><creatorcontrib>Habel, Laurel A.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Emerson, Marc A.</au><au>Achacoso, Ninah S.</au><au>Benefield, Halei C.</au><au>Troester, Melissa A.</au><au>Habel, Laurel A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors</atitle><jtitle>Cancer</jtitle><date>2021-02-23</date><risdate>2021</risdate><volume>127</volume><issue>11</issue><spage>1847</spage><epage>1856</epage><pages>1847-1856</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>In this cohort study of 23,680 AET-eligible patients, AIAN women had the lowest AET-adherence by the end of the 5-year period and total underutilization (combining initiation and adherence) was greatest among AIAN (70.6%), followed by Black (69.6%), Hispanic (63.2%), non-Hispanic white (58.7%), and Asian/Pacific Islander (52.3%), underscoring the AET-treatment gap.</abstract><pmid>33620753</pmid><doi>10.1002/cncr.33423</doi></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2021-02, Vol.127 (11), p.1847-1856
issn 0008-543X
1097-0142
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8191495
source Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection); Alma/SFX Local Collection
title Initiation and adherence to adjuvant endocrine therapy among urban, insured American Indian/Alaskan Native breast cancer survivors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T10%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Initiation%20and%20adherence%20to%20adjuvant%20endocrine%20therapy%20among%20urban,%20insured%20American%20Indian/Alaskan%20Native%20breast%20cancer%20survivors&rft.jtitle=Cancer&rft.au=Emerson,%20Marc%20A.&rft.date=2021-02-23&rft.volume=127&rft.issue=11&rft.spage=1847&rft.epage=1856&rft.pages=1847-1856&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.33423&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8191495%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33620753&rfr_iscdi=true